Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Stryker Corp (NY:SYK)

394.21 +2.01 (+0.51%)
Official Closing Price Updated: 7:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Pfizer, Ford And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Stryker reports first quarter 2023 operating results
From Stryker Corporation
Via GlobeNewswire
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today
Via Benzinga
3 Medical Device Stocks Outpacing the Healthcare Industry This Year
All three of these companies have seen double-digit increases in their share prices this year. 
Via The Motley Fool
Global Payments, MGM Resorts And 3 Stocks To Watch Heading Into Monday
With US stock futures trading slightly higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Earnings Preview For Stryker
Via Benzinga
2 Top Stocks to Buy in April and Hold Forever
The need for healthcare goods and/or services is here to stay. 
Via The Motley Fool
The Latest Analyst Ratings for Stryker
Via Benzinga
Should Investors Buy This Dividend Growth Stock?
This medical devices company is already up in 2023. Should you buy it? 
Via The Motley Fool
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
Stryker Expects Good Momentum In 2023 Despite Some Volatility
Via Benzinga
These 3 Stocks Might Be Getting a Little Too Expensive
These are promising businesses, but you might want to hold off on buying shares -- for now. 
Via The Motley Fool
Healthcare Innovation Drives Medical Device Makers To New Highs
Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base. 
Via MarketBeat
Microsoft To Rally Around 9%? Here Are 10 Other Analyst Forecasts For Monday
RBC Capital raised the price target for Pinterest, Inc. (NYSE: PINS) from $26 to $30. RBC Capital analyst Brad Erickson maintained a Sector Perform rating. Pinterest shares gained 1.5% to $27.68 in... 
Via Benzinga
Stryker to announce financial results for its first quarter of fiscal year 2023
From Stryker Corporation
Via GlobeNewswire
Stryker Now Offers the Only FDA-Cleared Pyrocarbon Bearing Material Option for Shoulder Hemiarthroplasty
From Stryker
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
Via Benzinga
Stryker announces Annual Meeting of Shareholders
From Stryker Corporation
Via GlobeNewswire
3 Dividend Champions for Long-Term Income
Dividend Champions have grown their dividend payout for at least 25 years in a row. Here are three to keep in mind for long-term income. 
Via InvestorPlace
Portfolio Highlights: Quarterly Movers & Shakers, March 2023
High quality stocks that generated strong double-digit gains during the past three months. 
Via Talk Markets
Are These Medical Device Makers Getting Ready To Rally?
Current trends and changing demographics are behind growth of medical technology companies. An aging population and a shift to in-home care are among factors. 
Via MarketBeat
BAX: A “Hospital Stock” To Avoid
Baxter International's shares are down nearly 50% over the past three years and have underperformed the broader healthcare industry. 
Via Talk Markets
Interview With David Rolfe of Wedgewood Partners
Motley Fool analyst John Rotonti recently seized the opportunity to interview David Rolfe. 
Via The Motley Fool
Stryker's Q Guidance System Scores FDA Clearance For Cranial Applications
Via Benzinga
Stryker’s Q Guidance System for cranial applications receives FDA clearance
From Stryker
Via Business Wire
Stryker declares a $0.75 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
General Motors, Bank of America And 2 Other Stocks Insiders Are Selling
The Nasdaq dropped by more than 100 points on Monday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Price Reversals From Recent Highs In Stocks
Stryker Corp is in a bullish phase on both the daily and weekly charts. Since Friday, the stock had a brick pattern confirmed by Monday’s action. 
Via Talk Markets
Silicon Laboratories, Credit Acceptance, Stryker And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Stryker reports 2022 operating results and 2023 outlook
From Stryker Corporation
Via GlobeNewswire
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.